TEVA-ATENOLOL 50 MG — DIN 01912062
ATENOLOL : 50 MG · TEVA CANADA LIMITED · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TEVA-ATENOLOL?
TEVA-ATENOLOL 50 MG contains ATENOLOL : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 01912062, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 24-Jul-2015. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is TEVA-ATENOLOL used for?
TEVA-ATENOLOL (atenolol) tablets are indicated in patients with mild or moderate hypertension. It is usually used in combination with other drugs, particularly a thiazide diuretic. TEVA-ATENOLOL tablets are also indicated in the long-term management of patients with angina pectoris due to ischemic heart disease.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Atenolol cost around the world?
Atenolol is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Belgium publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Brazil | preco fabrica (ex-factory ceiling) | 7 | 67 | BRL███.██ |
| United States | acquisition | 3 | 53 | USD███.██ |
| Saudi Arabia | public | 34 | 41 | SAR███.██ |
| South Africa | single exit price | 29 | 31 | ZAR███.██ |
| Spain | PVP con IVA (public price) | 27 | 27 | EUR███.██ |
| Morocco | PPV (public price) | 8 | 20 | MAD███.██ |
| Australia | ex-manufacturer | 9 | 18 | AUD███.██ |
| Bahrain | retail (max) | 6 | 16 | BHD███.██ |
| United Arab Emirates | public | 10 | 15 | AED███.██ |
| Sweden | AIP (pharmacy purchase price) | 5 | 15 | SEK███.██ |
| Norway | max AUP (pharmacy retail) | 2 | 11 | NOK███.██ |
| Romania | max producer price | 6 | 8 | RON███.██ |
| Belgium | public | 6 | 6 | EUR███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Greece | producer price (ex-factory) | 4 | 4 | EUR███.██ |
| Slovakia | categorised final price | 2 | 2 | EUR███.██ |
338 pack listings across 162 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Atenolol pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Atenolol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
32 holders have a Canadian DIN containing Atenolol, across 87 DINs, of which 28 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 8 | 3 | NTP-ATENOL, TEVA-ATENOLOL | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 6 | 3 | IPG-ATENOLOL, MAR-ATENOLOL | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 4 | 3 | JAMP ATENOLOL TABLETS, JAMP-ATENOLOL | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 4 | 3 | ATENOLOL | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 3 | 3 | MINT-ATENOL | Sourceable in Canada |
| PHARMASCIENCE INC | 3 | 3 | PMS-ATENOLOL | Sourceable in Canada |
| PRO DOC LIMITEE | 3 | 3 | ATENOLOL | Sourceable in Canada |
| SUN PHARMA CANADA INC | 3 | 3 | TARO-ATENOLOL | Sourceable in Canada |
| APOTEX INC | 2 | 2 | APO-ATENOL TAB 100MG, APO-ATENOL TAB 50MG | Sourceable in Canada |
| SEARCHLIGHT PHARMA INC | 2 | 2 | TENORMIN | Sourceable in Canada |
| BIOMED PHARMA | 3 | 0 | BIO-ATENOLOL | No marketed DIN |
| LABORATOIRE RIVA INC. | 3 | 0 | RIVA-ATENOLOL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | 25 mg tablets - Supplied in bottles of 100. 50 mg tablets - Supplied in bottles of 100 and 500, in patient pack of 30, and in unit dose strips of 100. 100 mg tablets - Supplied in bottles of 100 and 500, in patient pack of 30, and in unit dose strips of 100. |
| Storage | Store between 15 - 30°C. Store at room temperature protected from light and moisture. |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Atenolol |
|---|---|
| ATC code | C07AB03 |
| AHFS class | 24:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01912062 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1912062 |
| Brand name | TEVA-ATENOLOL |
| Generic / active ingredient | ATENOLOL : 50 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | C07AB03 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C07AB |
| Current status | CANCELLED POST MARKET |
| Status date | 24-Jul-2015 |
| Original market date | 1991-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Hypertension: Initial 50 mg once daily, may increase to 100 mg. Angina: Initial 50 mg once daily, may increase to 100 mg once daily or 50 mg twice daily. Adjust for renal impairment.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Sinus bradycardia, A-V block (2nd/3rd degree), sick sinus syndrome, heart failure, cardiogenic shock, hypotension, severe peripheral arterial disorders, metabolic acidosis, hypersensitivity.
Warnings and precautions
Avoid abrupt cessation (risk of MI/arrhythmia). Caution in cardiac failure, Prinzmetal's angina, sinus bradycardia, thyrotoxicosis, and bronchospastic disorders.
Is Atenolol in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
28 of 87 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ATENOL TAB 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | 00773697 |
| APO-ATENOL TAB 50MG | 50 MG | TABLET | APOTEX INC | MARKETED | 00773689 |
| ATENOLOL | 50 MG | TABLET | PRO DOC LIMITEE | MARKETED | 00828807 |
| ATENOLOL | 100 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02238318 |
| ATENOLOL | 25 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02326701 |
| ATENOLOL | 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02238316 |
| ATENOLOL | 25 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02541564 |
| ATENOLOL | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | 00828793 |
| JAMP-ATENOLOL | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02367564 |
| JAMP-ATENOLOL | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02367556 |
2 · Same class — other molecules in ATC C07AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Metoprolol | AA-METOPROLOL SR · AG-METOPROLOL-L · APO-METOPROLOL · APO-METOPROLOL (TYPE L) · +44 more | 103 | 30 | Yes |
| Atenolol | ACT ATENOLOL · AG-ATENOLOL · APO-ATENOL TAB 100MG · APO-ATENOL TAB 50MG · +35 more | 87 | 28 | Yes |
| Bisoprolol | AG-BISOPROLOL · APO-BISOPROLOL · AVA-BISOPROLOL · BISOPROLOL · +19 more | 52 | 24 | Yes |
| Nebivolol | APO-NEBIVOLOL · BYSTOLIC · JAMP NEBIVOLOL · PRZ-NEBIVOLOL | 13 | 9 | Yes |
| Acebutolol | ACEBUTOLOL · ACEBUTOLOL - 400 · ACEBUTOLOL-100 · ACEBUTOLOL-200 · +20 more | 44 | 6 | Yes |
| Esmolol | BREVIBLOC INJECTION 10MG/ML · BREVIBLOC INJECTION 250MG/ML · BREVIBLOC LIQ IV 10MG/ML · BREVIBLOC LIQ IV 250MG/ML · +1 more | 5 | 2 | Yes |
| Landiolol | SIBBORAN | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C07A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C07AG | Carvedilol · Labetalol | 99 | 38 |
| C07AA | Nadolol · Oxprenolol · Pindolol · Propranolol · Sotalol · +1 more | 177 | 27 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVA-ATENOLOL called?
The same molecule, Atenolol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ATENOLOL | Latin | Brazil |
| Atenolol Viatris | Latin | Norway, Sweden |
| ATENOLAB | Latin | Brazil |
| Betaten | Latin | Bahrain, Saudi Arabia |
| Atenolol Medical Valley | Latin | Norway, Sweden |
| Tenormin | Latin | Australia, Bahrain |
| ZOTROL | Latin | Morocco |
| ANGIPRESS | Latin | Brazil |
| ABLOK | Latin | Brazil |
| Atenolol Accord | Latin | Sweden |
| Atenolol Orifarm | Latin | Sweden |
| Atenolol Teva | Latin | Sweden |
| ATENOR | Latin | Morocco |
| TENORMINE | Latin | Morocco |
| XYTENOL | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.